Mosaic Plans Mid-2000 Trials Of Hybriscan Rapid Blood Platelet Bacteria Test
This article was originally published in The Gray Sheet
Executive Summary
Mosaic Technologies plans to begin clinical trials in mid-2000 of an assay for bacteria in blood platelets, the firm says. The assay uses a combination hybridization/electrophoresis technology that dramatically accelerates hybridization, thereby yielding a low to moderate complexity test that can be performed in 30 minutes or less, Mosaic claims.